FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37731964> ?p ?o ?g. }

• Q37731964 description "article científic" @default.
• Q37731964 description "article scientifique" @default.
• Q37731964 description "articolo scientifico" @default.
• Q37731964 description "artigo científico" @default.
• Q37731964 description "artículu científicu espublizáu en 2017" @default.
• Q37731964 description "bilimsel makale" @default.
• Q37731964 description "scientific article published on 17 February 2017" @default.
• Q37731964 description "vedecký článok" @default.
• Q37731964 description "vetenskaplig artikel" @default.
• Q37731964 description "videnskabelig artikel" @default.
• Q37731964 description "vědecký článek" @default.
• Q37731964 description "wetenschappelijk artikel" @default.
• Q37731964 description "wissenschaftlicher Artikel" @default.
• Q37731964 description "наукова стаття, опублікована в лютому 2017" @default.
• Q37731964 description "научни чланак" @default.
• Q37731964 description "مقالة علمية نشرت في 17 فبراير 2017" @default.
• Q37731964 name "Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma" @default.
• Q37731964 name "Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma" @default.
• Q37731964 name "Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma" @default.
• Q37731964 type Item @default.
• Q37731964 label "Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma" @default.
• Q37731964 label "Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma" @default.
• Q37731964 label "Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma" @default.
• Q37731964 prefLabel "Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma" @default.
• Q37731964 prefLabel "Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma" @default.
• Q37731964 prefLabel "Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma" @default.
• Q37731964 P1433 Q37731964-34A1BC6E-6EB1-42C7-B67E-3F81730DBA20 @default.
• Q37731964 P1476 Q37731964-EDA8E250-E3B2-452F-9FF5-6CA911E1E757 @default.
• Q37731964 P2093 Q37731964-0A31A771-99CA-4D13-9662-4890F889135E @default.
• Q37731964 P2093 Q37731964-101EB410-DA98-465A-B09B-8EE5EE8870D6 @default.
• Q37731964 P2093 Q37731964-37B92EDD-10BE-465B-ABFB-74D8802658F6 @default.
• Q37731964 P2093 Q37731964-D126C18F-34F7-4884-AB74-190F6FD32A42 @default.
• Q37731964 P2093 Q37731964-DCF8CE8A-1A2A-46A2-AB87-E99021A17C52 @default.
• Q37731964 P2093 Q37731964-F27EEE1B-AA09-4FD7-B9CE-6DDDEC9614DD @default.
• Q37731964 P2860 Q37731964-07A8A0FB-1CB3-4285-B1E1-27BD99F13ACB @default.
• Q37731964 P2860 Q37731964-129835E4-848A-4760-B071-AA5B24B17FB6 @default.
• Q37731964 P2860 Q37731964-15393714-0FC2-4B7C-B9E9-253DA99A1690 @default.
• Q37731964 P2860 Q37731964-1A89630E-F6EA-4BEB-98BF-59A14AB68F1A @default.
• Q37731964 P2860 Q37731964-24C6D8F3-CA42-498D-A538-0E97CE9BCA9D @default.
• Q37731964 P2860 Q37731964-30E23C37-A437-4E33-9445-5C9B7ED3B1EB @default.
• Q37731964 P2860 Q37731964-3E959C6A-51F0-474A-9008-BF8DCEF6D6AA @default.
• Q37731964 P2860 Q37731964-49014EE9-791A-4F90-A636-986DB0D8B277 @default.
• Q37731964 P2860 Q37731964-5256B71C-B53C-433C-B0ED-9C3EF842866F @default.
• Q37731964 P2860 Q37731964-74C43CF9-D990-40BF-B3F5-C5896A3D285A @default.
• Q37731964 P2860 Q37731964-75EFDFF0-DDD1-47C6-AAFD-40A6EB1D227E @default.
• Q37731964 P2860 Q37731964-7C9F16E9-451A-4E4B-9ED3-F8103B4D4375 @default.
• Q37731964 P2860 Q37731964-81AFA49D-D659-462D-A483-5B63BE7B3A59 @default.
• Q37731964 P2860 Q37731964-88AFBEAE-1D6E-4D35-BD49-31127329D593 @default.
• Q37731964 P2860 Q37731964-89CC89B3-90BD-47FA-8319-0772D805AF69 @default.
• Q37731964 P2860 Q37731964-8C766528-B8A0-4879-B45F-B4887B96EDE0 @default.
• Q37731964 P2860 Q37731964-9FD52555-8E17-42C4-B87A-9D9217A80253 @default.
• Q37731964 P2860 Q37731964-AAF07C38-1840-4163-9150-1B6EBF5A1C6C @default.
• Q37731964 P2860 Q37731964-B0413F05-886A-43D2-91AE-ED8924B36AF5 @default.
• Q37731964 P2860 Q37731964-B4F019DE-1F63-426D-B08E-BCFADFB95F92 @default.
• Q37731964 P2860 Q37731964-BAE50AC4-DD98-4C64-8AE9-281464D33E56 @default.
• Q37731964 P2860 Q37731964-C21290EF-6D30-4CF9-ACE2-D9CE3974AF5A @default.
• Q37731964 P2860 Q37731964-C527C7F1-C9C0-4F61-A39C-1D300FFEA1BA @default.
• Q37731964 P2860 Q37731964-CC12C30F-029E-465D-9F88-87046B5579ED @default.
• Q37731964 P2860 Q37731964-CFEF0355-477B-4946-A746-C44F667E9A21 @default.
• Q37731964 P2860 Q37731964-DCB7E7AA-BFBB-47A5-9B94-A89FA1E46723 @default.
• Q37731964 P2860 Q37731964-DD686310-5FB2-49F6-9649-0A380020E9AA @default.
• Q37731964 P2860 Q37731964-DD6D5082-8227-4E37-ADC8-32316B3DBB78 @default.
• Q37731964 P2860 Q37731964-F3BFE9D1-8616-4062-AC21-45B697928F2B @default.
• Q37731964 P2860 Q37731964-F6F70D20-94FC-49C0-B0D2-746C8B69A809 @default.
• Q37731964 P2860 Q37731964-FA1C7557-8D56-475A-801A-91B9BC6FCCB0 @default.
• Q37731964 P304 Q37731964-B0E12B71-1CB7-45AF-8210-BEFCBC566810 @default.
• Q37731964 P31 Q37731964-63D7BBAE-3C1B-415B-AEC6-7974F0B083EA @default.
• Q37731964 P356 Q37731964-A6AD0BC4-DA14-4FB4-8C26-46C095A0BBB8 @default.
• Q37731964 P433 Q37731964-3C2948C3-94A3-41AF-BC15-2B939C8DF812 @default.
• Q37731964 P478 Q37731964-EA178E0C-EA14-47D7-A74F-3C52E13FC0E4 @default.
• Q37731964 P577 Q37731964-54361644-5B05-400C-B2E3-2FA640F94A22 @default.
• Q37731964 P698 Q37731964-179B1B6E-1FAD-4504-8339-224F8EF767DA @default.
• Q37731964 P932 Q37731964-45AB0784-77E3-4E56-8585-FC0F3DAF7E3C @default.
• Q37731964 P356 MCO.2017.1169 @default.
• Q37731964 P698 28413681 @default.
• Q37731964 P1433 Q27725125 @default.
• Q37731964 P1476 "Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma" @default.
• Q37731964 P2093 "Jamile M Shammo" @default.
• Q37731964 P2093 "Melissa L Larson" @default.
• Q37731964 P2093 "Parameswaran Venugopal" @default.
• Q37731964 P2093 "Reem Karmali" @default.
• Q37731964 P2093 "Stephanie A Gregory" @default.
• Q37731964 P2093 "Teresa O'Brien" @default.
• Q37731964 P2860 Q24646379 @default.
• Q37731964 P2860 Q28204313 @default.
• Q37731964 P2860 Q28246277 @default.
• Q37731964 P2860 Q28248195 @default.
• Q37731964 P2860 Q28274089 @default.
• Q37731964 P2860 Q33378775 @default.
• Q37731964 P2860 Q33390098 @default.
• Q37731964 P2860 Q33407265 @default.
• Q37731964 P2860 Q33416593 @default.
• Q37731964 P2860 Q33773306 @default.
• Q37731964 P2860 Q33934326 @default.
• Q37731964 P2860 Q34146682 @default.
• Q37731964 P2860 Q34184706 @default.
• Q37731964 P2860 Q34566901 @default.
• Q37731964 P2860 Q34598460 @default.
• Q37731964 P2860 Q34621900 @default.
• Q37731964 P2860 Q34742742 @default.

• next